NO20060820L - Behandling av akutt inflammatorisk tilstand - Google Patents

Behandling av akutt inflammatorisk tilstand

Info

Publication number
NO20060820L
NO20060820L NO20060820A NO20060820A NO20060820L NO 20060820 L NO20060820 L NO 20060820L NO 20060820 A NO20060820 A NO 20060820A NO 20060820 A NO20060820 A NO 20060820A NO 20060820 L NO20060820 L NO 20060820L
Authority
NO
Norway
Prior art keywords
acute inflammatory
groups
treatment
phosphate
bodies
Prior art date
Application number
NO20060820A
Other languages
English (en)
Norwegian (no)
Inventor
Anthony E Bolton
Arkady Mandel
Original Assignee
Vasogen Ireland Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vasogen Ireland Ltd filed Critical Vasogen Ireland Ltd
Publication of NO20060820L publication Critical patent/NO20060820L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01GCOMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
    • C01G19/00Compounds of tin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/661Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A61K31/6615Compounds having two or more esterified phosphorus acid groups, e.g. inositol triphosphate, phytic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/662Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82BNANOSTRUCTURES FORMED BY MANIPULATION OF INDIVIDUAL ATOMS, MOLECULES, OR LIMITED COLLECTIONS OF ATOMS OR MOLECULES AS DISCRETE UNITS; MANUFACTURE OR TREATMENT THEREOF
    • B82B3/00Manufacture or treatment of nanostructures by manipulation of individual atoms or molecules, or limited collections of atoms or molecules as discrete units
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01GCOMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
    • C01G15/00Compounds of gallium, indium or thallium

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Nanotechnology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Manufacturing & Machinery (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20060820A 2003-07-21 2006-02-20 Behandling av akutt inflammatorisk tilstand NO20060820L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48907103P 2003-07-21 2003-07-21
PCT/CA2004/001053 WO2005007169A2 (fr) 2003-07-21 2004-07-20 Traitement de conditions inflammatoires aigues

Publications (1)

Publication Number Publication Date
NO20060820L true NO20060820L (no) 2006-04-10

Family

ID=34079469

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20060820A NO20060820L (no) 2003-07-21 2006-02-20 Behandling av akutt inflammatorisk tilstand

Country Status (15)

Country Link
US (1) US20070238708A1 (fr)
EP (1) EP1658086A2 (fr)
JP (1) JP2006528136A (fr)
KR (1) KR20060037369A (fr)
CN (1) CN1826123A (fr)
AU (1) AU2004257375A1 (fr)
BR (1) BRPI0412882A (fr)
CA (1) CA2533084A1 (fr)
EA (1) EA200600297A1 (fr)
IL (1) IL173068A0 (fr)
MA (1) MA28002A1 (fr)
MX (1) MXPA06000805A (fr)
NO (1) NO20060820L (fr)
WO (1) WO2005007169A2 (fr)
ZA (1) ZA200601458B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007131329A1 (fr) * 2006-05-12 2007-11-22 Vasogen Ireland Limited Traitement des troubles liés au dysfonctionnement du système ubiquitine-protéasome
EP2142196A4 (fr) 2007-03-29 2010-06-30 Nat Jewish Health Lipides tensioactifs, compositions et utilisation de ceux-ci
CN105434354A (zh) * 2009-06-03 2016-03-30 斯昆申技术控股有限责任公司 用于治疗深部组织疼痛的制剂
US20120232034A1 (en) * 2009-08-21 2012-09-13 Henk-Andre Kroon Vesicular formulations
GB201205642D0 (en) 2012-03-29 2012-05-16 Sequessome Technology Holdings Ltd Vesicular formulations
ES2879383T3 (es) 2015-06-30 2021-11-22 Sequessome Tech Holdings Limited Fórmulas mixtas

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3346526C2 (de) * 1983-12-22 1986-12-11 A. Nattermann & Cie GmbH, 5000 Köln Pharmazeutisches Präparat zur therapeutischen Behandlung von rheumatischen Erkrankungen
FR2658418B1 (fr) * 1990-02-20 1994-09-02 Synthelabo Compositions pharmaceutiques a base de phospholipides.
WO1995023592A1 (fr) * 1994-03-04 1995-09-08 The University Of British Columbia Compositions a base de liposomes et procedes de traitement de l'atherosclerose
US20020115609A1 (en) * 1997-07-14 2002-08-22 Hayat Onyuksel Materials and methods for making improved micelle compositions
EP1133301A1 (fr) * 1998-11-26 2001-09-19 Britannia Pharmaceuticals Limited Combinaisons antiasthmatiques a base de phospholipides tensio-actifs
EP1248628A4 (fr) * 1999-12-14 2004-08-04 Sky High Llc Compositions phospholipidiques utiles en tant qu'agents anti-inflammatoires
US20020001614A1 (en) * 2000-02-10 2002-01-03 Kent Jorgensen Lipid-based drug delivery systems containing phospholipase A2 degradable lipid derivatives and the therapeutic uses thereof
US20030040505A1 (en) * 2000-03-31 2003-02-27 The Regents Of The University Of California Synthetic phospholipids to ameliorate atherosclerosis and other inflammatory conditions
CA2368656A1 (fr) * 2002-01-21 2003-07-21 Vasogen Ireland Limited Appariement recepteur-ligand pour produire une reeaction anti-inflammatoire
US20040009216A1 (en) * 2002-04-05 2004-01-15 Rodrigueza Wendi V. Compositions and methods for dosing liposomes of certain sizes to treat or prevent disease
WO2004024123A1 (fr) * 2002-09-16 2004-03-25 Vasogen Ireland Limited Acceleration du retablissement suite a des traumas
WO2004037270A1 (fr) * 2002-10-25 2004-05-06 Vasogen Ireland Limited Regulation de cyclooxygenase avec des liposomes pg
DE10255106A1 (de) * 2002-11-24 2004-06-09 Novosom Ag Liposomale Glucocorticoide

Also Published As

Publication number Publication date
KR20060037369A (ko) 2006-05-03
MXPA06000805A (es) 2006-04-18
EP1658086A2 (fr) 2006-05-24
AU2004257375A1 (en) 2005-01-27
US20070238708A1 (en) 2007-10-11
MA28002A1 (fr) 2006-07-03
IL173068A0 (en) 2006-06-11
BRPI0412882A (pt) 2006-10-03
CA2533084A1 (fr) 2005-01-27
EA200600297A1 (ru) 2006-08-25
ZA200601458B (en) 2007-05-30
WO2005007169A3 (fr) 2005-09-22
JP2006528136A (ja) 2006-12-14
CN1826123A (zh) 2006-08-30
WO2005007169A2 (fr) 2005-01-27

Similar Documents

Publication Publication Date Title
BRPI0411904B8 (pt) formulações inaláveis para o tratamento de hipertensão pulmonar
CO5160320A1 (es) Metodos y composiciones para la prevencion de tolerancia a medicamentos das.
BRPI0407375A (pt) Métodos para tratar dor por meio da administração de um antagonista do fator de crescimento neural e u nsaid e composições contendo os mesmos
ATE433980T1 (de) Gyraseinhibitoren und deren verwendungen
HK1044545A1 (zh) 贝他分泌酶组合物及其方法
NO20054343L (no) Behandling av immunologiske lidelser ved anvendelse av agonister av interleukin-21/interleukin-21 reseptor
BR9710689A (pt) Processo para tratar diarr-ia aguda e para proporcionar terapia a um mam¡fero tendo diarr-ia e prepara-Æo terap-utica para redu-Æo de sintomas de diarr-ia
CY1112281T1 (el) Αναστολεις διπεπτιδυλ πεπτιδασης για τη θεραπεια του διαβητη
ATE318583T1 (de) Verfahren zur herstellung von partikeln mit einem aus dem amorphen und/oder metastabilen kristallinen zustand in einen kristallinen zustand überführten bereich
WO2003068171A3 (fr) Procede et composition pour le traitement d'une inflammation et de troubles neurologiques associes au sida
BR9813811A (pt) "composições farmacêuticas compreendendo micelas que compreendem glicocorticosteróide lipofìlico e apenas um único tensoativo"
BRPI0411319A (pt) compostos terapeuticamente ativos e sua utilização
WO2002058694A3 (fr) Procede de traitement de tumeurs et de cancers hematologiques
ATE221775T1 (de) Verfahren zur herstellung eines aus einzelnen schichten bestehenden laminats
ATE397058T1 (de) In vitro rekonstituierte lagen des menschlichen hornhautepithels und verfahren zur herstellung davon
WO2007062413A3 (fr) Utilisation d'inhibiteurs du parp-1
SE9603725D0 (sv) New teatment
ATE273052T1 (de) Zusammensetzung enthaltend folsäure und zink für das verbessern der semen qualität
ATE550491T1 (de) Vorrichtung zum verschieben einer zungenschiene sowie höheneinstellbare rollvorrichtung
BR0315462A (pt) Composto, composição farmacêutica, uso de um composto, método para o tratamento de um sujeito que sofre de uma condição patológica ou de doença susceptìvel de alìvio por antagonismo de receptores de ltd4 e produto de combinação
WO2005007169A3 (fr) Traitement de conditions inflammatoires aigues
BRPI0414139A (pt) métodos e composições para tratar infecções por herpes
BG106748A (en) Method and compositions for treating pulmonary diseases
Gupta et al. Interdigital tinea pedis (dermatophytosis simplex and complex) and treatment with ciclopirox 0.77% gel
TNSN06199A1 (en) Shape-adapted absorbent article with improved absorption capacity

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application